메뉴 건너뛰기




Volumn 41, Issue 3, 2010, Pages 316-322

Atorvastatin for diabetic macular edema in patients with diabetes mellitus and elevated serum cholesterol

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; ATORVASTATIN; CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

EID: 77952604460     PISSN: 15428877     EISSN: None     Source Type: Journal    
DOI: 10.3928/15428877-20100430-04     Document Type: Article
Times cited : (30)

References (27)
  • 2
    • 34548476007 scopus 로고    scopus 로고
    • Diabetic dyslipidemia and atherosclerosis: Evidence from clinical trials
    • DOI 10.1007/s11883-007-0013-8
    • Farmer JA. Diabetic dyslipidemia and atherosclerosis: evidence from clinical trials. Curr Atheroscler Rep. 2007;9:162-168. (Pubitemid 47376987)
    • (2007) Current Atherosclerosis Reports , vol.9 , Issue.2 , pp. 162-168
    • Farmer, J.A.1
  • 3
    • 0023623014 scopus 로고
    • Abnormal lipoprotein metabolism in non-insulin diabetes mellitus
    • Reaven GM. Abnormal lipoprotein metabolism in non-insulin diabetes mellitus. Am J Med. 1987;83:31-40.
    • (1987) Am J Med , vol.83 , pp. 31-40
    • Reaven, G.M.1
  • 4
    • 0026093735 scopus 로고
    • The Wisconsin Epidemiologic Study of Diabetic Retinopathy, XII: Relationship of serum cholesterol to retinopathy and hard exudates
    • Klein BEK, Moss SE, Klein R, Surawicz TS. The Wisconsin Epidemiologic Study of Diabetic Retinopathy, XII: relationship of serum cholesterol to retinopathy and hard exudates. Ophthalmology. 1991;98:1261-1265.
    • (1991) Ophthalmology , vol.98 , pp. 1261-1265
    • Klein, B.E.K.1    Moss, S.E.2    Klein, R.3    Surawicz, T.S.4
  • 5
    • 0029757496 scopus 로고    scopus 로고
    • Association of elevated serum lipid levels with retinal hard exudates in diabetic retinopathy: ETDRS report 22
    • Chew EY, Klein ML, Ferris FL III. Association of elevated serum lipid levels with retinal hard exudates in diabetic retinopathy: ETDRS report 22. Arch Ophthalmol. 1996;114:1079-1084.
    • (1996) Arch Ophthalmol , vol.114 , pp. 1079-1084
    • Chew, E.Y.1    Klein, M.L.2    Ferris III, F.L.3
  • 6
    • 0041358796 scopus 로고    scopus 로고
    • Diabetic retinopathy and diabetic macular edema: Pathophysiology, screening, and novel therapies
    • Ciulla TA, Amador AG, Zinman B. Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. Diabetes Care. 2003;26:2653-2664.
    • (2003) Diabetes Care , vol.26 , pp. 2653-2664
    • Ciulla, T.A.1    Amador, A.G.2    Zinman, B.3
  • 7
    • 0348048874 scopus 로고    scopus 로고
    • Diabetic retinopathy
    • Frank RN. Diabetic retinopathy. N Engl J Med. 2004;350:48-58.
    • (2004) N Engl J Med , vol.350 , pp. 48-58
    • Frank, R.N.1
  • 8
    • 0022347471 scopus 로고
    • Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1
    • Early Treatment Diabetic Retinopathy Study research group
    • Early Treatment Diabetic Retinopathy Study research group. Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol. 1985;103:1796-1806.
    • (1985) Arch Ophthalmol , vol.103 , pp. 1796-1806
  • 9
    • 0026324005 scopus 로고
    • Modified grid laser photocoagulation for diffuse diabetic macular edema: Long-term visual results
    • Lee CM, Olk RJ. Modified grid laser photocoagulation for diffuse diabetic macular edema: long-term visual results. Ophthalmology. 1991;98:1594-1602.
    • (1991) Ophthalmology , vol.98 , pp. 1594-1602
    • Lee, C.M.1    Olk, R.J.2
  • 10
    • 0024259722 scopus 로고
    • Enhancement of platelet aggregation by low-density lipoproteins from IDDM patients
    • Watanabe J, Wohltman HJ, Klein RL, Colwell JA, Lopes-Virella MF. Enhancement of platelet aggregation by low-density lipoprotein from IDDM patients. Diabetes. 1988;37:1652-1657. (Pubitemid 19004949)
    • (1988) Diabetes , vol.37 , Issue.12 , pp. 1652-1657
    • Watanabe, J.1    Wohltmann, H.J.2    Klein, R.L.3    Colwell, J.A.4    Lopes-Virella, M.F.5
  • 11
    • 0018082233 scopus 로고
    • Lipoproteins and the inhibitory effect of human endothelial cells on platelet function
    • Nordoy A, Svensson B, Weibe D, Hoak JC. Lipoproteins and the inhibitory effect of human endothelial cells on platelet function. Circ Res. 1978;43:527-534. (Pubitemid 9022295)
    • (1978) Circulation Research , vol.43 , Issue.4 , pp. 527-534
    • Nordoy, A.1    Svensson, B.2    Wiebe, D.3    Hoak, J.C.4
  • 13
    • 0003042048 scopus 로고
    • Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits
    • Ma PT, Gil G, Südhof TC, Bilheimer DW, Goldstein JL, Brown MS. Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits. Proc Natl Acad Sci U S A. 1986;83:8370-8374.
    • (1986) Proc Natl Acad Sci U S A , vol.83 , pp. 8370-8374
    • Ma, P.T.1    Gil, G.2    Südhof, T.C.3    Bilheimer, D.W.4    Goldstein, J.L.5    Brown, M.S.6
  • 14
    • 0032956961 scopus 로고    scopus 로고
    • Natural statins and stroke risk
    • Furberg CD. Natural statins and stroke risk. Circulation. 1999;99:185-188.
    • (1999) Circulation , vol.99 , pp. 185-188
    • Furberg, C.D.1
  • 15
    • 0014519590 scopus 로고
    • A double blind controlled trial of clofibrate in the treatment of DR
    • Harrold BP, Marmion VJ, Gough KR. A double blind controlled trial of clofibrate in the treatment of DR. Diabetes. 1969;18:285-291.
    • (1969) Diabetes , vol.18 , pp. 285-291
    • Harrold, B.P.1    Marmion, V.J.2    Gough, K.R.3
  • 17
    • 34548638774 scopus 로고    scopus 로고
    • Simvastatin: Present and future perspectives
    • Robinson JG. Simvastatin: present and future perspectives. Expert Opin Pharmacother. 2007;8:2159-2227
    • (2007) Expert Opin Pharmacother , vol.8 , pp. 2159-2227
    • Robinson, J.G.1
  • 18
    • 0036180956 scopus 로고    scopus 로고
    • Simvastatin retards progression of retinopathy in diabetic patients with hypercholesterolemia
    • DOI 10.1016/S0168-8227(02)00052-9, PII S0168822701003412
    • Sen K, Misra A, Kumar A, Pandey RM. Simvastatin retards progression of retinopathy in diabetic patients with hypercholesterolemia. Diabetes Res Clin Pract. 2002;56:1-11. (Pubitemid 34170743)
    • (2002) Diabetes Research and Clinical Practice , vol.56 , Issue.1 , pp. 1-11
    • Sen, K.1    Misra, A.2    Kumar, A.3    Pandey, R.M.4
  • 19
    • 1842608809 scopus 로고    scopus 로고
    • Lipid-lowering drug atorvastatin as an adjunct in the management of diabetic macular edema
    • DOI 10.1016/j.ajo.2003.11.017, PII S0002939403014247
    • Gupta A, Gupta V, Thapar S, Bhansali A. Lipid-lowering drug atorvastatin as an adjunct in the management of diabetic macular edema. Am J Ophthalmol. 2004;137:675-682. (Pubitemid 38446682)
    • (2004) American Journal of Ophthalmology , vol.137 , Issue.4 , pp. 675-682
    • Gupta, A.1    Gupta, V.2    Thapar, S.3    Bhansali, A.4
  • 20
    • 0025995666 scopus 로고
    • The effect of lipid lowering on diabetic retinopathy
    • Gordon B, Chang S, Kavanagh M, et al. The effect of lipid lowering on diabetic retinopathy. Am J Ophthalmol. 1991;112:385-391.
    • (1991) Am J Ophthalmol , vol.112 , pp. 385-391
    • Gordon, B.1    Chang, S.2    Kavanagh, M.3
  • 21
    • 0015348189 scopus 로고
    • Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge
    • Friedewald WJ, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
    • (1972) Clin Chem , vol.18 , pp. 499-502
    • Friedewald, W.J.1    Levy, R.I.2    Fredrickson, D.S.3
  • 22
    • 0035897696 scopus 로고    scopus 로고
    • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
    • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
    • (2001) JAMA , vol.285 , pp. 2486-2497
  • 23
    • 77952663887 scopus 로고    scopus 로고
    • Clinical Practice Recommendations 2007
    • American Diabetes Association
    • American Diabetes Association. Clinical Practice Recommendations 2007. Diabetes Care. 2007;30(suppl 1):S16-S17.
    • (2007) Diabetes Care , vol.30 , Issue.SUPPL. 1
  • 24
    • 0032511583 scopus 로고    scopus 로고
    • Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
    • United Kingdom Prospective Diabetes Study Group
    • United Kingdom Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
    • (1998) Lancet , vol.352 , pp. 837-853
  • 25
    • 0032511580 scopus 로고    scopus 로고
    • Tight blood pressure control and risk of macrovascular complications in type 2 diabetes: UKPDS 38
    • United Kingdom Prospective Diabetes Study Group
    • United Kingdom Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703-713.
    • (1998) BMJ , vol.317 , pp. 703-713
  • 26
    • 0020319988 scopus 로고
    • Stimulation of arterial endothelial cell prostacyclin synthesis by high density lipoproteins
    • Fleisher LN, Tall AR, Witte LD, et al. Stimulation of arterial endothelial cell prostacyclin synthesis by high density lipoproteins. J Biol Chem. 1982;257:6653-6655. (Pubitemid 12022261)
    • (1982) Journal of Biological Chemistry , vol.257 , Issue.12 , pp. 6653-6655
    • Fleisher, L.1    Tall, A.R.2    Witte, L.D.3
  • 27
    • 0035572718 scopus 로고    scopus 로고
    • Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors
    • Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3-methylgyratyl coenzyme a reductase inhibitors. Arterioscler Thromb Vasc Biol. 2001;21:1712-1719. (Pubitemid 34219772)
    • (2001) Arteriosclerosis, Thrombosis, and Vascular Biology , vol.21 , Issue.11 , pp. 1712-1719
    • Takemoto, M.1    Liao, J.K.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.